ARCHIVES

Judge Invalidates Bristol-Myers’ Claims For The Administration Of Taxol.

This article is from The Cancer Letter archive.

Vol. 26 No. 09 | March 3, 2000

Download PDF Visit The Full Archive

Related Articles

Sunitinib Prolongs Survival In Poor Prognosis, Study Finds

July 31, 2009

In Brief: FASEB Recommends $11.75 Billion NIH Budget; Natcher Wins House Appropriations Chairmanship

December 11, 1992

Obey Raps Reagan Administration For Blocking Report On Formaldehyde Danger

March 27, 1981

Survey Finds. Bush Signs Stopgap Funding Measure;

October 5, 2007

Celebrex Studies Show Polyp Reduction, Point To Challenges In Biomarker Validation

April 28, 2006

New Design For NCI’s CancerNet Wins Prestigious Web Site Design Awards.

November 17, 2000